Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

Journal of the American College of Cardiology

Volumn 57, Issue 1, 2011, Pages 29-36

  Damman, Peter ^a   Beijk, Marcel A M ^a   Kuijt, Wichert J ^a   Verouden, Niels J W ^a   Van Geloven, Nan ^a   Henriques, José P S ^a   Baan, Jan ^a   Vis, Marije M ^a   Meuwissen, Martijn ^a   Van Straalen, Jan P ^a   Fischer, Johan ^a   Koch, Karel T ^a   Piek, Jan J ^a   Tijssen, Jan G P ^a   De Winter, Robbert J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLOPIDOGREL; GLUCOSE; HEPARIN; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CORONARY STENT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 78650585689     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.06.053     Document Type: Article

References (23)

1. D.A. Morrow, E.M. Antman, and A. Charlesworth TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation An intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
2. S.Q. Khan, P. Quinn, J.E. Davies, and L.L. Ng N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction Heart 94 2008 40 43
3. M. Kosiborod, S.S. Rathore, and S.E. Inzucchi Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes Circulation 111 2005 3078 3086
4. P. Ortolani, A. Marzocchi, and C. Marrozzini Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention Eur Heart J 29 2008 1241 1249
5. N.S. Anavekar, J.J. McMurray, and E.J. Velazquez Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285 1295
6. R.J. Aviles, A.T. Askari, and B. Lindahl Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction N Engl J Med 346 2002 2047 2052
7. L.A. Stevens, J. Coresh, T. Greene, and A.S. Levey Assessing kidney functionmeasured and estimated glomerular filtration rate N Engl J Med 354 2006 2473 2483
8. J.S. Hochman, L.A. Sleeper, and J.G. Webb Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock N Engl J Med 341 1999 625 634
9. G. De Luca, H. Suryapranata, J.P. Ottervanger, and E.M. Antman Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts Circulation 109 2004 1223 1225
10. F.E. Harrell Jr, K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
11. M.J. Pencina, R.B. D'Agostino Sr, R.B. D'Agostino Jr, and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
12. T. Brgger-Andersen, H. Aarsetoy, H. Grundt, H. Staines, and D.W. Nilsen The long-term prognostic value of multiple biomarkers following a myocardial infarction Thromb Res 123 2008 60 66
13. B. Zethelius, L. Berglund, and J. Sundstrom Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2008 2107 2116
14. P. Deedwania, M. Kosiborod, and E. Barrett Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism Circulation 117 2008 1610 1619
15. A. Undas, I. Wiek, E. Stepien, K. Zmudka, and W. Tracz Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome Diabetes Care 31 2008 1590 1595
16. J.A. de Lemos, D.A. Morrow, and J.H. Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
17. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/nonST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/NonST-Elevation Myocardial Infarction) J Am Coll Cardiol 50 2007 e1 e157
18. R.J. de Winter, J.C. Fischer, T. de Jongh, J.P. van Straalen, R. Bholasingh, and G.T. Sanders Different time frames for the occurrence of elevated levels of cardiac troponin T and C-reactive protein in patients with acute myocardial infarction Clin Chem Lab Med 38 2000 1151 1153
19. G. Liuzzo, L.M. Baisucci, and J.R. Gallimore Enhanced inflammatory response in patients with preinfarction unstable angina J Am Coll Cardiol 34 1999 1696 1703
20. M.A. Hlatky, P. Greenland, and D.K. Arnett Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2009 2408 2416
21. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
22. E. Bates, C. Bode, and M. Costa Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction Circulation 117 2008 886 896
23. D.A. Morrow, E.M. Antman, and L. Parsons Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3 JAMA 286 2001 1356 1359